Pulmonary aging increases MUC5AC in the airway epithelium, increasing the risk of carcinogenesis

肺部老化增加气道上皮中的MUC5AC,增加致癌风险

基本信息

  • 批准号:
    10583805
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

The lung is known to undergo changes with aging, including alterations in the airway epithelium. Older people have higher rates of lung cancer, with over 70% of lung cancers diagnosed in those over age 65. This suggests that the aged lung cell is particularly sensitive to carcinogenic insults. Very little is known about how cellular changes with aging in the lung may lead to carcinogenesis. We have compelling pilot data showing that MUC5AC is increased in the airways of healthy older people, as well as in a murine model of aging. We have also recently found that we can increase the expression of MUC5AC in the airway epithelium of cells from young donors by inducing oxidative stress or producing DNA damage. These findings suggest that not only is MUC5AC increased in the aging lung, but also that specific aging-related cell stresses drive the upregulation of MUC5AC/muc5ac in aging. The upregulation of MUC5AC in older cells serves as a link between aging and the increasing risk of developing lung cancer. In particular, the increased expression of MUC5AC makes the airway epithelium more susceptible to DNA damage and then potentially creates an environment that is favorable to carcinogenesis. Our preliminary data suggest that lung aging leads to decreases in Sirtuin 1 (SIRT1). SIRT 1 is known to play a prominent role in aging and DNA damage. SIRT1 is also known to deacetylate Mitogen-activated protein kinase phosphatase 1 (MKP1). Decreased SIRT1 activity leads to increased acetylation of MKP1, which increases MKP1 activity. Inhibition of MKP1 in lung cells from aged donors restores MUC5AC to low, youthful levels. This suggests it plays a key role in the upregulation of MUC5AC in aging. These data led us to hypothesize that: Aging leads to cellular changes that increase MUC5AC expression, promoting lung cancer development. In this proposal we will 1) Determine the aging mechanisms that promote the upregulation of MUC5AC. 2) Elucidate the mechanisms linking aging processes to increased expression of MUC5AC, and determine how to rejuvenate aged cells. 3) Identify the consequences of aging and upregulated Muc5ac in a murine model of lung cancer.
已知肺随着年龄的增长而发生变化,包括气道上皮的改变。老年人 肺癌的发病率更高,超过70%的肺癌诊断为65岁以上的人。这 提示老化的肺细胞对致癌物的损伤特别敏感。我们对它是如何产生的知之甚少 随着年龄的增长,肺中的细胞变化可能导致癌变。 我们有令人信服的试验数据显示,MUC 5AC在健康老年人的气道中增加, 以及小鼠衰老模型。我们最近还发现,我们可以增加 MUC 5AC通过诱导氧化应激或产生DNA在来自年轻供体的细胞的气道上皮中的表达 损害这些发现表明,不仅MUC 5AC在老化的肺中增加,而且特异性MUC 5AC在老化的肺中增加。 衰老相关的细胞应激驱动衰老中MUC 5AC/muc 5ac的上调。MUC 5AC的上调 在衰老细胞中的蛋白质是衰老和肺癌风险增加之间的联系。特别是, MUC 5AC的表达增加使气道上皮细胞更容易受到DNA损伤, 潜在地创造了一个有利于致癌的环境。 我们的初步数据表明,肺老化导致Sirtuin 1(SIRT 1)减少。据了解,SIRT 1可以发挥 在衰老和DNA损伤中的重要作用。SIRT 1还已知使促分裂原活化蛋白脱乙酰化 激酶磷酸酶1(MKP 1)。SIRT 1活性降低导致MKP 1乙酰化增加, 增加MKP 1活性。抑制来自老年供体的肺细胞中的MKP 1使MUC 5AC恢复到低的年轻状态 程度.这表明它在衰老中MUC 5AC的上调中起关键作用。 这些数据使我们假设:衰老导致细胞变化,增加MUC 5AC表达, 促进肺癌的发展。在本提案中,我们将1)确定促进衰老的机制 MUC 5AC的上调。2)阐明了衰老过程与 MUC 5AC,并确定如何使衰老细胞恢复活力。3)确定老化的后果和上调 小鼠肺癌模型中的Muc 5ac。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kristina L Bailey其他文献

Kristina L Bailey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kristina L Bailey', 18)}}的其他基金

Lung Innate COVID-19 Defense Specific to Veterans Risk Characteristics
针对退伍军人风险特征的肺部先天性 COVID-19 防御
  • 批准号:
    10151991
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Lung Innate COVID-19 Defense Specific to Veterans Risk Characteristics
针对退伍军人风险特征的肺部先天性 COVID-19 防御
  • 批准号:
    10359086
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Mucociliary clearance in aging
衰老过程中的粘膜纤毛清除
  • 批准号:
    9478026
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Mucociliary clearance in aging
衰老过程中的粘膜纤毛清除
  • 批准号:
    9157024
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Mucociliary clearance in aging
衰老过程中的粘膜纤毛清除
  • 批准号:
    9355099
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Summer Undergraduate Alcohol Research Program
暑期本科酒精研究计划
  • 批准号:
    10594242
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Summer Undergraduate Alcohol Research Program
暑期本科酒精研究计划
  • 批准号:
    9893776
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
  • 批准号:
    8617198
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
  • 批准号:
    8436337
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Biphasic alcohol regulation of TLR2 in airway epithelium
气道上皮 TLR2 的双相酒精调节
  • 批准号:
    8037205
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了